Skip to main content

Joern Aldag

CEO

HOOKIPA Pharma Inc.

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Joern Aldag

Joern Aldag is recorded as CEO at HOOKIPA Pharma Inc.. HOOKIPA Pharma Inc. reported in an 8-K filed July 26, 2024 that Joern Aldag resigned as director, effective July 23, 2024. The proxy statement of HOOKIPA Pharma Inc. reports total compensation of $1,130,427 for Joern Aldag in fiscal 2023, including a base salary of $567,451. Disclosed compensation is on record for 5 fiscal years. Joern Aldag has spoken on 3 earnings calls across 1 company, most recently for HOOKIPA Pharma Inc. on March 15, 2023.

“Mr. Aldag also resigned from his position as a director of the Company on July 23, 2024 following his separation as Chief Executive Officer as stipulated by his employment agreement with Hookipa Biotech GmbH ("Hookipa Biotech"), the Company's wholly owned subsidiary, pursuant to which Mr. Aldag provided services to the Company.”
HOOKIPA Pharma Inc. Form 8-K, filed July 26, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

  • HOOKIPA Pharma Inc.

    CEO

    Proxy statement

    Current

    Start not stated–present

  • HOOKIPA Pharma Inc.

    Board Member

    Proxy statement

    Start not stated–2024-07-23

Company network

Recorded roles and call appearances connecting this person to public companies.

HOOKIPA Pharma Inc.

Current role

CEO

3 appearances Latest appearance 2023-03-15

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2023 HOOKIPA Pharma Inc. $567,451 $1,130,427
2022 HOOKIPA Pharma Inc. $389,601 $1,250,408
2021 HOOKIPA Pharma Inc. $572,334 $2,605,450
2019 HOOKIPA Pharma Inc. $469,205 $6,367,981
2018 HOOKIPA Pharma Inc. $361,600 $547,592

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

  • Executive change Resigned: director

    HOOKIPA Pharma Inc.

  • Earnings call

    HOOKIPA Pharma Inc. Q4 FY2022 Earnings Call

    HOOKIPA Pharma Inc.

  • Earnings call

    HOOKIPA Pharma Inc. Q4 FY2021 Earnings Call

    HOOKIPA Pharma Inc.

  • Earnings call

    HOOKIPA Pharma Inc. Q4 FY2020 Earnings Call

    HOOKIPA Pharma Inc.